Clinical & Regulatory Challenges in Developing Psychedelics as Therapeutics

Time: 3:25 pm
day: Day One

Details:

  • Designing clinical trials that meet regulatory requirements without inadvertently stifling market access
  • Managing the impact of CSA schedule 1 status during development
  • Building an optimal case for appropriate down-scheduling post-approval

Speakers: